Patent Assignment
Reel/Frame 014872/0188
Assignment of Assignor's Interest
Recorded: 2004-01-08
Pages: 3
Assignors
KOSITPRAPA, UNCHALEE
Executed: 2003-12-18
NANGIA, AVINASH
Executed: 2003-12-18
CARDINAL, JOHN
Executed: 2003-12-18
GOLDFARB, ROBERT
Executed: 2003-12-24
Assignee
ANDRX LABS LLC
4955 ORANGE DRIVE, DAVIE, FLORIDA, 33314
Covered Property
(1)
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Supplemental Patent and Trademark Security Agreement
Nov 10, 2003
From: ANDA, INC.; ANDRX LABS, LLC; ANDRX PHARMACEUTICALS, LLC
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 014683/0075 →
Second Supplemental Security Agreement
Jan 25, 2005
From: ANDRX LABS, LLC; ANDA, INC.; ANDRX PHARMACEUTICALS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 016180/0093 →
Release of Security Interest
Oct 26, 2005
From: BANK OF AMERICA, N.A., AS AGENT
To: ANDA, INC.; ANDRX CORPORATION; ANDRX LABS, LLC; ANDRX LABORATORIES, INC.
Reel/Frame 016674/0980 →
Assignment of Assignor's Interest
Mar 18, 2009
From: ANDRX LABS, LLC
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 022413/0374 →
Change of Name
Jul 5, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 030741/0511 →
Assignment of Assignor's Interest
Jan 20, 2017
From: ALLERGAN FINANCE, LLC
To: ACTAVIS HOLDCO US, INC.
Reel/Frame 041449/0799 →
Change of Name
Jan 20, 2017
From: ACTAVIS, INC.
To: ALLERGAN FINANCE, LLC
Reel/Frame 041459/0788 →